WHO ICTRP trial
Two preparations, two cycles, two sequences, random intersected tigerrilol…
ChiCTR1800015091 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800015091 |
|---|---|
| Public title | Two preparations, two cycles, two sequences, random intersected tigerrilol tablets and postprandial human bioequivalence test. |
| Scientific title | Two preparations, two cycles, two sequences, random intersected tigerrilol tablets and postprandial human bioequivalence test. |
| Primary sponsor | Medical Ethics Committee of Chinese PLA General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | Bioequivalence |
| Interventions | T---R:T---R;R---T:R---T |
| Registration date | Mar 7, 2018 |
| Target size | T---R:40;R---T:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: